Tirzepatide

Tirzepatide is a peptide that activates both GIP and GLP-1 receptors.

Metabolic Research

Select specification 11 listed

Specification: 5mg × 10 vials
Catalog code: TR5
Material category: Peptide

Choose a contact to discuss this specification, quantity or customization.

For laboratory research use only. Not for human use.

The research context

A closer look at Tirzepatide.

Dual incretin-receptor signaling and metabolic research

Documentation

Certificate of Analysis.

About quality & COA

Certificate of Analysis

Tirzepatide

Sample: TIRZEPATIDE 30MG
Spec.: 30MG
Laboratory: Optiq Health Labs
Report ID: 1663.OPT.261005-R1
Report date: October 8, 2026

Technical Details Product information

Tirzepatide

CAS: 2023788-19-2
formula: C225H348N48O68
mass: 4813.45
sequence: Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{Lys(C20 diacid-gamma-Glu-(AEEA)2)}-AFVQWLIAGGPSSGAPPPS-NH2
solubility: DMSO 50 mg/mL (10.39 mM; sonication)

Storage: Powder: -80°C for 2 years or -20°C for 1 year. Solution: -80°C for 6 months or -20°C for 1 month. Sealed, protected from moisture and light.

FAQ

Tirzepatide questions

What is Tirzepatide?

Tirzepatide is a peptide that activates both GIP and GLP-1 receptors.

Which specifications and packs are listed?

5mg × 10 vials; 10mg × 10 vials; 15mg × 10 vials; 20mg × 10 vials; 30mg × 10 vials; 40mg × 10 vials; 50mg × 10 vials; 60mg × 10 vials; 80mg × 10 vials; 100mg × 10 vials; 120mg × 10 vials.

Can I request a different specification?

Yes. Contact our team on WhatsApp or Telegram to discuss specifications and customization.

Where can I view its COA?

Select View COA on this product page or browse Quality & COA.

Let's discuss your specification

Make Tirzepatide part of your project.

Your enquiry includes the selected specification and catalog code.